Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea
· Delayed Price · Currency is KRW 12,350
-240 (-1.91%)
Feb 19, 2025, 9:00 AM KST
KRX:000520 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 18, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 261,762 | 96,901 | 108,894 | 106,418 | 128,907 | 128,479 | Upgrade
|
| Market Cap Growth | 234.23% | -11.01% | 2.33% | -17.45% | 0.33% | 2.18% | Upgrade
|
| Enterprise Value | 403,089 | 272,367 | 265,842 | 202,048 | 200,995 | 180,425 | Upgrade
|
| Last Close Price | 12330.00 | 6700.00 | 7800.00 | 7509.09 | 9184.43 | 9316.22 | Upgrade
|
| PE Ratio | - | 58.25 | - | - | 96.16 | 163.41 | Upgrade
|
| PS Ratio | 0.97 | 0.49 | 0.61 | 0.79 | 1.05 | 1.06 | Upgrade
|
| PB Ratio | 1.49 | 0.76 | 0.87 | 1.62 | 2.03 | 2.06 | Upgrade
|
| P/TBV Ratio | 1.96 | 0.77 | 0.89 | 1.65 | 2.09 | 2.12 | Upgrade
|
| P/FCF Ratio | 128.68 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 14.67 | 8.25 | 26.21 | 75.11 | 16.58 | 12.13 | Upgrade
|
| EV/Sales Ratio | 1.90 | 1.39 | 1.48 | 1.51 | 1.63 | 1.49 | Upgrade
|
| EV/EBITDA Ratio | 38.28 | 23.03 | 29.52 | 39.53 | 18.72 | 20.48 | Upgrade
|
| EV/EBIT Ratio | 79.23 | 42.16 | 66.19 | 505.45 | 30.74 | 37.62 | Upgrade
|
| EV/FCF Ratio | 198.16 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.83 | 1.38 | 1.27 | 1.91 | 1.49 | 1.50 | Upgrade
|
| Debt / EBITDA Ratio | 13.80 | 14.87 | 17.68 | 24.55 | 8.79 | 10.63 | Upgrade
|
| Debt / FCF Ratio | 71.44 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.55 | 0.54 | 0.62 | 0.64 | 0.66 | 0.73 | Upgrade
|
| Inventory Turnover | 3.98 | 4.27 | 4.59 | 3.53 | 3.18 | 3.21 | Upgrade
|
| Quick Ratio | 0.34 | 0.22 | 0.27 | 0.38 | 0.48 | 0.82 | Upgrade
|
| Current Ratio | 0.75 | 0.48 | 0.56 | 0.63 | 0.73 | 1.16 | Upgrade
|
| Return on Equity (ROE) | -0.76% | 1.31% | -0.03% | -8.27% | 2.13% | 1.33% | Upgrade
|
| Return on Assets (ROA) | 0.83% | 1.11% | 0.86% | 0.12% | 2.18% | 1.81% | Upgrade
|
| Return on Capital (ROIC) | 1.00% | 1.37% | 1.05% | 0.14% | 2.60% | 2.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.90% | 3.20% | 1.79% | 0.38% | 7.03% | 4.14% | Upgrade
|
| Earnings Yield | -0.45% | 1.72% | -0.03% | -5.02% | 1.04% | 0.61% | Upgrade
|
| FCF Yield | 0.78% | -12.90% | -40.71% | -29.52% | -7.17% | -2.57% | Upgrade
|
| Dividend Yield | 0.00% | - | - | - | 0.74% | 0.73% | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | 68.55% | 77.63% | Upgrade
|
| Buyback Yield / Dilution | 7.68% | -3.42% | -0.82% | -2.85% | -0.13% | -15.56% | Upgrade
|
| Total Shareholder Return | 7.68% | -3.42% | -0.82% | -2.85% | 0.62% | -14.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.